498
Views
33
CrossRef citations to date
0
Altmetric
Review

Potential role of phytochemicals in metabolic syndrome prevention and therapy

, &
Pages 1987-2002 | Published online: 01 Oct 2019

References

  • Ervin RB . Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report . 2009;5:1–7.
  • Alberti KG , Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med . 1998;15:539–553. doi:10.1002/(ISSN)1096-9136 9686693
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA . 2001;285:2486–2497. doi:10.1001/jama.285.19.2486.11368702
  • Ford ES . Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the. U.S. Diabet Care . 2005;28:2745–2749. doi:10.2337/diacare.28.11.2745
  • Grundy SM , Brewer HB Jr , Cleeman JI , Smith SC Jr , Lenfant C . American Heart Association; National Heart, Lung, and Blood Institute. Definition of Metabolic Syndrome. Report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation . 2004;109:433–438. doi:10.1161/01.CIR.0000111245.75752.C6 14744958
  • Yang L , Colditz GA . Prevalence of overweight and obesity in the United States, 2007–2012. JAMA Intern Med . 2015;175:1412–1413. doi:10.1001/jamainternmed.2015.2405 26098405
  • Ranasinghe P , Mathangasinghe Y , Jayawardena R , Hills AP , Misra A . Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health . 2017;17:101. doi:10.1186/s12889-017-4041-1 28109251
  • Farrell GC , Haczeyni F , Chitturi S . Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease. Adv Exp Med Biol . 2018;1061:19–44. doi:10.1007/978-981-10-8684-7_3 29956204
  • Soleimani M . Insulin resistance and hypertension: new insights. Kidney Int . 2015;87:497–499. doi:10.1038/ki.2014.392 25723632
  • Henao-Mejia J , Elinav E , Elinav E , Jin C , et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature . 2012;482:179–185. doi:10.1038/nature10809 22297845
  • Skurk T , Alberti-Huber C , Herder C , Hauner H . Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab . 2007;92:1023–1033. doi:10.1210/jc.2006-1055 17164304
  • Hirosumi G , Tuncman L , Chan L , et al. A central role for JNK in obesity and insulin resistance. Nature . 2002;420:333–336. doi:10.1038/nature01137 12447443
  • Marchesini G , Bugianesi E , Forlani G , et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology . 2003;37:917–923. doi:10.1053/jhep.2003.50161 12668987
  • Propst A , Propst T , Judmaier G , Vogel W . Prognosis in nonalcoholic steatohepatitis. Gastroenterology . 1995;108:1607. doi:10.1016/0016-5085(95)90724-6
  • Lau LHS , Wong SH . Microbiota, obesity and NAFLD. Adv Exp Med Biol . 2018;106:111–125.
  • Mehta NN , McGillicuddy FC , Anderson PD , et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes . 2010;59:172–181. doi:10.2337/db09-0367 19794059
  • Kim JJ , Sears DD . TLR4 and insulin resistance. Gastroenterol Res Pract . 2010;2010:212563. doi:10.1155/2010/212563 20814545
  • Babio N , Bulló M , Salas-Salvadó J . Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr . 2009;12:1607–1617. doi:10.1017/S1368980009990449 19689829
  • Macready AL , George TW , Chong MF , et al. Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease-FLAVURS: a randomized controlled trial. Am J Clin Nutr . 2014;99:479–489. doi:10.3945/ajcn.113.074237 24452238
  • Martínez-González MA , Salas-Salvadó J , Estruch R , Corella D , Fitó M , Ros E . Benefits of the Mediterranean diet: insights from the PREDIMED study. Prog Cardiovasc Dis . 2015;58:50–60. doi:10.1016/j.pcad.2015.04.003 25940230
  • Karalis DG . Achieving optimal lipid goals in the metabolic syndrome: a global health problem. Atherosclerosis . 2014;237:191–193. doi:10.1016/j.atherosclerosis.2014.07.039 25240624
  • Scalbert A , Manach C , Morand C , Remesy C . Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr . 2005;45:287–306. doi:10.1080/1040869059096 16047496
  • Shahidi F , Naczk M . Food Phenolics, Sources, Chemistry, Effects, Applications . Lancaster: PA Technomic Publishing Co Inc; 1995.
  • Clifford MN , Scalbert A . Ellagitannins-occurrence in food, bioavailability and cancer prevention. J Food Sci Agricol . 2000;80:118–125.
  • Abourashed EA . Review of stilbenes: applications in chemistry, life sciences and materials science. J Nat Prod . 2017;80:577. doi:10.1021/acs.jnatprod.7b00089
  • Thompson LU , Robb P , Serraino M , Cheung F . Mammalian lignan production from various foods. Nutr Cancer . 1991;16:43–52. doi:10.1080/01635589109514139 1656395
  • Beukes N , Levendal RA , Frost CL . Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders. J Pharm Pharmacol . 2014;66:1505–1525. doi:10.1111/jphp.12267 24821379
  • Patel MD , Thompson PD . Phytosterols and vascular disease. Atherosclerosis . 2006;186:12–19. doi:10.1016/j.atherosclerosis.2005.10.026 16325823
  • Wang TH , Lin TF . Monascus rice products. Adv Food Nutr Res . 2007;53:123–159. doi:10.1016/S1043-4526(07)53004-4 17900498
  • Marinangeli CP , Kassis AN , Jain D , Ebine N , Cunnane SC , Jones PJ . Comparison of composition and absorption of sugarcane policosanols. Br J Nutr . 2007;97:381–388. doi:10.1017/S0007114507336763 17298709
  • Del Rio D , Rodriguez-Mateos A , Spencer JP , Tognolini M , Borges GA . Crozier dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal . 2013;18:1818–1892. doi:10.1089/ars.2012.4581 22794138
  • Nagao T , Komine Y , Soga S , et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde modified LDL in men. Am J Clin Nutr . 2005;81:122–129. doi:10.1093/ajcn/81.1.122 15640470
  • Harpaz E , Tamir S , Weinstein A , Weinstein Y . The effect of caffeine on energy balance. J Basic Clin Physiol Pharmacol . 2017;28:1–10. doi:10.1515/jbcpp-2016-0090 27824614
  • Basu A , Sanchez K , Leyva MJ , et al. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr . 2010;29:31–40. doi:10.1080/07315724.2010.10719814 20595643
  • Suliburska J , Bogdanski P , Szulinska M , Stepien M , Pupek-Musialik D , Jablecka A . Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res . 2012;149:315–322. doi:10.1007/s12011-012-9448-z 22581111
  • Diepvens K , Westerterp KR , Westerterp-Plantenga MS . Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol . 2007;292:77–85. doi:10.1152/ajpregu.00630.2006
  • Evans BA , Sato M , Sarwar M , Hutchinson DS , Summers RJ . Ligand-directed signalling at beta-adrenoceptors. Br J Pharmacol . 2010;159:1022–1038. doi:10.1111/j.1476-5381.2009.00602.x 20132209
  • Collins L , Cornelius M , Voegel LR , Walker JF , Stamford BA . Effect of caffeine and/or cigarette smoking on resting energy expenditure. Int J Obes Relat Metab Disord . 1994;18:551–556.7951476
  • Shixian Q , VanCrey B , Shi J , Kakuda Y , Jiang Y . Green tea extract thermogenesis-induced weight loss by epigallocatechin gallate inhibition of catechol-O-methyltransferase. J Med Food . 2006;9:451–458. doi:10.1089/jmf.2006.9.451 17201629
  • Gregersen NT , Bitz C , Krog-Mikkelsen I , et al. Effect of moderate intakes of different tea catechins and caffeine on acute measures of energy metabolism under sedentary conditions. Br J Nutr . 2009;102:1187–1194. doi:10.1017/S0007114509371779 19445822
  • Brown AL , Lane J , Coverly J , et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr . 2009;101:886–894. doi:10.1017/S0007114508116270 18710606
  • Berube-Parent S , Pelletier C , Dore J , Tremblay A . Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br J Nutr . 2005;94:432–436. doi:10.1079/bjn20051458 16176615
  • Boschmann M , Thielecke F . The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: A pilot study. J Am Coll Nutr . 2007;26:389–395.
  • Rudelle S , Ferruzzi MG , Cristiani I , Moulin J , Macé K , Acheson K . Effect of a thermogenic beverage on 24 hr energy metabolism in humans. Obesity (Silver Spring) . 2007;15:349–355. doi:10.1038/oby.2007.535 17299107
  • Westerterp-Plantenga MS , Lejeune MP , Kovacs EM . Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res . 2005;13:1195–1204. doi:10.1038/oby.2005.142 16076989
  • Chu SL , Fu H , Yang JX , et al. A randomized double-blind placebo-controlled study of Pu’er tea extract on the regulation of metabolic syndrome. Chin J Integr Med . 2011;17:492–498. doi:10.1007/s11655-011-0781-4 21725873
  • Belcaro G , Ledda A , Hu S , Cesarone MR , Feragalli B , Dugall M . Greenselect Phytosome for borderline metabolic syndrome. Evid Based Complement Alternat Med . 2013;11:1–7.
  • Maki KC , Reeves MS , Farmer M , et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr . 2009;139:264–270. doi:10.3945/jn.108.098293 19074207
  • Vieira Senger AE , Schwanke CHA , Gomes I , Valle Gottlieb MG . Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J Nutr Health Aging . 2012;16:738–742. doi:10.1007/s12603-012-0081-5 23131813
  • Yang TY , Chou JI , Ueng KC , Chou MY , Yang JJ , Lin-Shiau SY . Weight reduction effect of Puerh tea in male patients with metabolic syndrome. Phytother Res . 2014;28:1096–1101. doi:10.1002/ptr.5111 24399768
  • Calò LA , Vertolli U , Davis PA , et al. Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients. Clin Nutr . 2014;33:437–442. doi:10.1016/j.clnu.2013.06.010 23845383
  • Mandel SA , Weinreb O , Amit T , Youdim MB . Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green teapolyphenols. Front Biosci (Schol Ed) . 2012;1:581–598. doi:10.2741/s286
  • Wang H , Nair MG , Strasburg GM , et al. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod . 1999;62:294–296. doi:10.1021/np980501m 10075763
  • Huang WY , Liu YM , Wang J , Wang XN , Li CY . Anti-inflammatory effect of the blueberry anthocyanins malvidin-3-glucoside and malvidin-3-galactoside in endothelial cells. Molecules . 2014;19:12827–12841. doi:10.3390/molecules190811211 25153881
  • Lau FC , Bielinski DF , Joseph JA . Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharideactivated BV2 microglia. J Neurosci Res . 2007;85:1010–1017. doi:10.1002/(ISSN)1097-4547 17265471
  • Kalea AZ , Clark K , Schuschke DA , Klimis-Zacas DJ . Vascular reactivity is affected by dietary consumption of wild blueberries in the Sprague- Dawley rat. J Med Food . 2009;12:21–28. doi:10.1089/jmf.2008.0078 19298192
  • Martineau LC , Couture A , Spoor D , et al. Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine . 2006;13:612–623. doi:10.1016/j.phymed.2006.08.005 16979328
  • Vendrame S , Daugherty A , Kristo AS , Riso P , Klimis-Zacas D . Wild blueberry (Vaccinium angustifolium) consumption improves inflammatory status in the obese Zucker rat model of the metabolic syndrome. J Nutr Biochem . 2013;24:1508–1512. doi:10.1016/j.jnutbio.2012.12.010 23465589
  • Seymour EM , Singer AA , Kirakosyan A , Urcuyo-Llanes DE , Kaufman PB , Bolling SF . Altered hyperlipidemia, hepatic steatosis, and hepatic peroxisome proliferator-activated receptors in rats with intake of tart cherry. J Med Food . 2008;11:252–259. doi:10.1089/jmf.2007.658 18598166
  • Yang L , Ling W , Du Z , et al. Effects of anthocyanins on cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr . 2017;8:684–693. doi:10.3945/an.116.014852 28916569
  • Basu A , Fu DX , Wilkinson M , et al. Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res . 2010;30:462–469. doi:10.1016/j.nutres.2010.06.016 20797478
  • Castro-Acosta ML , Stone SG , Mok JE , et al. Apple and blackcurrant polyphenol-rich drinks decrease postprandial glucose, insulin and incretin response to a highcarbohydrate meal in healthy men and women. J Nutr Biochem . 2017;49:53–62. doi:10.1016/j.jnutbio.2017.07.013 28886437
  • Kim H , Simbo S , Fang C , et al. Açaí (Euterpe oleracea Mart.) beverage consumption improves biomarkers for inflammation but not glucose-or lipid-metabolism in individuals with metabolic syndrome in a randomized, double blinded, placebo-controlled clinical trial. Food Funct . 2018;9:3097–3103. doi:10.1039/C8FO00595H 29850709
  • Medjakovic S , Jungbauer A . Pomegranate: a fruit that ameliorates metabolic syndrome. Food Funct . 2013;4(1):19–39. doi:10.1039/c2fo30034f 23060097
  • Moazzen H , Alizadeh M . Effects of pomegranate juice on cardiovascular risk factors in patients with metabolic syndrome: a double-blinded, randomized crossover controlled trial. Plant Foods Hum Nutr . 2017;72(2):126–133. doi:10.1007/s11130-017-0605-6 28303364
  • Aprotosoaie AC , Miron A , Trifan A , Luca VS , Costache II . The cardiovascular effects of cocoa polyphenols-an overview. Diseases . 2016;17:4.
  • Fisher ND , Hughes M , Gerhard-Herman M , Hollenbergh NK . Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens . 2003;21:2281–2286. doi:10.1097/00004872-200312000-00016 14654748
  • Faridi Z , Njike VY , Dutta S , Ali A , Katz DL . Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr . 2008;88:58–63. doi:10.1093/ajcn/88.1.58 18614724
  • Magrone T , Russo MA , Jirillo E . Cocoa and dark chocolate polyphenols: from biology to clinical applications. Front Immunol . 2017;8:677. doi:10.3389/fimmu.2017.00677 28649251
  • Shiina Y , Funabashi N , Lee K , Murayama T , Nakamura K , Wakatsuki Y . Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol . 2009;131:424–429. doi:10.1016/j.ijcard.2008.11.048 18045712
  • Napoli C , Ignarro LJ . Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res . 2009;32:1103–1108. doi:10.1007/s12272-009-1801-1 19727602
  • Actis-Goretta L , Ottaviani JI , Fraga CG . Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem . 2006;54:229–234. doi:10.1021/jf052263o 16390204
  • Grassi D , Lippi C , Necozione S , Desideri G , Ferri C . Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr . 2005;81:611–614. doi:10.1093/ajcn/81.3.611 15755830
  • Desideri G , Kwik-Uribe C , Grassi D , et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the cocoa, cognition, and aging (CoCoA) study. Hypertension . 2012;60:794–801. doi:10.1161/HYPERTENSIONAHA.112.193060 22892813
  • Haghighat N , Rostami A , Eghtesadi S , Shidfar F , Heidari I , Hoseini A . The effects of dark chocolate on glycemic control and blood pressure in hypertensive diabetic patients: a randomized clinical trial. Razi J Med Sci . 2013;20:78–86.
  • Ramirez-Sanchez I , Taub PR , Taub PR , Ciaraldi TP , et al. Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients. Int J Cardiol . 2013;168:3982–3990. doi:10.1016/j.ijcard.2013.06.089 23870648
  • Mellor DD , Sathyapalan T , Kilpatrick ES , Beckett S , Atkin SL . High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients. Diabet Med . 2010;27:1318–1321.20968113
  • Dorenkott MR , Griffin LE , Goodrich KM , et al. Oligomeric cocoa procyanidins possess enhanced bioactivity compared to monomeric and polymeric cocoa procyanidins for preventing the development of obesity, insulin resistance, and impaired glucose tolerance during high-fat feeding. J Agric Food Chem . 2014;62:2216–2227. doi:10.1021/jf500333y 24559282
  • Strat KM , Rowley TJ 4th , Smithson AT , et al. Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders. J Nutr Biochem . 2016;35:1–21. doi:10.1016/j.jnutbio.2015.12.008 27560446
  • Epstein J , Sanderson IR , Macdonald TT . Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr . 2010;103:1545–1557. doi:10.1017/S0007114509993291 20100380
  • Liu W , Zhai Y , Heng X , Che FY , Chen W , Sun D . Oral bioavailability of curcumin: problems and advancements. J Drug Target . 2016;24:694–702. doi:10.3109/1061186X.2016.1157883 26942997
  • Gupta SC , Patchva S , Aggarwal BB . Therapeutic roles of curcumin: lessons learned from clinical trials. Aaps J . 2013;15:195–218. doi:10.1208/s12248-012-9432-8 23143785
  • Kunnumakkara AB , Bordoloi D , Padmavathi G , et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol . 2017;174:1325–1348. doi:10.1111/bph.13621 27638428
  • Milani A , Basirnejad M , Shahbazi S , Bolhassani A . Carotenoids: biochemistry, pharmacology and treatment. Br J Pharmacol . 2017;174:1290–1324. doi:10.1111/bph.13625 27638711
  • Yang YS , Su YF , Yang W , Lee YH , Chou JI , Ueng KC . Lipid‐lowering effects of curcumin in patients with metabolic syndrome: a randomized, double‐blind, placebo‐controlled trial. Phytother Res . 2014;28:1770–1777. doi:10.1002/ptr.5197 25131839
  • Alwi I , Santoso T , Suyono S , et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med Indones . 2008;40:201–210.19151449
  • Melo ISV , Santos AFD , Bueno NB . Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: systematic review and meta-analysis of randomized controlled trials. Pharmacol Res . 2018;128:137–144. doi:10.1016/j.phrs.2017.09.010 28928074
  • Anand P , Kunnumakkara AB , Newman RA , Aggarwal BB . Bioavailability of curcumin: problems and promises. Mol Pharm . 2007;4:807–818. doi:10.1021/mp700113r 17999464
  • Shakeri A , Sahebkar A . Opinion paper: phytosome: a fatty solution for efficient formulation of phytopharmaceuticals. Recent Pat Drug Deliv Formul . 2016;10:7–10. doi:10.2174/1872211309666150813152305 26268361
  • Panahi Y , Khalili N , Sahebi E , Namazi S , Simental-Mendía LE , Majeed M . A Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Res . 2018;68:403–409. doi:10.1055/s-0044-101752
  • Cicero AFG , Sahebkar A , Fogacci F , Bove M , Giovannini M , Borghi C . Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Eur J Nutr . 2019. doi:10.1007/s00394-019-01916-7
  • Tuck KL , Hayball PJ . Major phenolic compounds in olive oil: metabolism and health effects. J Nutr Biochem . 2002;13:636–644. doi:10.1016/S0955-2863(02)00229-2 12550060
  • Ruiz-Canela M , Martinez-Gonzalez MA . Olive oil in the primary prevention of cardiovascular disease. Maturitas . 2011;68:245–250. doi:10.1016/j.maturitas.2010.12.002 21216542
  • Visioli F , Bernardini E . Extra virgin olive oil’s polyphenols: biological activities. Curr Pharm Des . 2011;17:786–804. doi:10.2174/138161211795428885 21443485
  • Estruch R , Martinez-Gonzalez MA , Corella D , et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med . 2006;145:1–11. doi:10.7326/0003-4819-145-1-200607040-00004 16818923
  • Covas MI , Nyyssonen K , Poulsen HE , et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med . 2006;145:333–341. doi:10.7326/0003-4819-145-5-200609050-00006 16954359
  • Tsartsou E , Proutsos N , Castanas E , Kampa M . Network meta-analysis of metabolic effects of olive-oil in humans shows the importance of olive oil consumption with moderate polyphenol levels as part of the mediterranean diet. Front Nutr . 2019;12:6:6.
  • Ho GT , Kase ET , Wangensteen H , Barsett H . Effect of phenolic compounds from elderflowers on glucose- and fatty acid uptake in human myotubes and HepG2-cells. Molecules . 2017;6:22–90.
  • Sayin FK , Buyukbas S , Basarali K , Alp H , Toy H , Ugurcu V . Effects of Silybum marianum extract on high fat diet induced metabolic disorders in rats. Polish J Food Nutr Sci . 2016;66:43–49. doi:10.1515/pjfns-2015-0014
  • Bahmani M , Shirzad H , Rafieian S , Rafieian‐Kopaei M . Silybum marianum: beyond hepatoprotection. J Evid Based Complementary Altern Med . 2015;20:292–301. doi:10.1177/2156587215571116 25686616
  • Fehér J , Lengyel G . Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Curr Pharm Biotechnol . 2012;13:210–217. doi:10.2174/138920112798868818 21466434
  • Tajmohammadi A , Razavi BM , Hosseinzadeh H . Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review. Phytother Res . 2018;32:1933–1949. doi:10.1002/ptr.6153 30015401
  • de Avelar CR , Pereira EM , de Farias Costa PR , de Jesus RP , de Oliveira LPM . Effect of silymarin on biochemical indicators in patients with liver disease: systematic review with meta-analysis. World J Gastroenterol . 2017;23:5004–5017. doi:10.3748/wjg.v23.i27.5004 28785154
  • Zhong S , Fan Y , Yan Q , et al. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials. Medicine . 2017;96:e9061. doi:10.1097/MD.0000000000009061 29245314
  • Fallahzadeh MK , Dormanesh B , Sagheb MM , et al. Effect of addition of silymarinto rennin angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: A randomized, double blind, placebocontrolled trial. Am J Kidney Dis . 2012;60:896–903. doi:10.1053/j.ajkd.2012.06.005 22770926
  • Zarvandi M , Rakhshandeh H , Abazari M , Shafiee‐Nick R , Ghorbani A . Safety and efficacy of a polyherbal formulation for the management of dyslipidemia and hyperglycemia in patients with advanced stage of type 2 diabetes. Biomed Pharmacother . 2017;89:69–75. doi:10.1016/j.biopha.2017.02.016 28214690
  • Menendez R , Mas R , Amor MA , et al. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro. Br J Clin Pharmacol . 2000;50:255–326. doi:10.1046/j.1365-2125.2000.00250.x 10971310
  • Ng CH , Leung KY , Huang Y , Chen ZY . Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters. J Agric Food Chem . 2005;53:6289–6293. doi:10.1021/jf051269a 16076108
  • Kassis AN , Kubow S , Jones PJ . Sugar cane policosanols do not reduce LDL oxidation in hypercholesterolemic individuals. Lipids . 2009;44:391–396. doi:10.1007/s11745-009-3295-5 19337769
  • Pons P , Rodriguez M , Robaina C , et al. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment. Int J Clin Pharmacol Res . 1994;14:27–33.7927958
  • Castano G , Fernandez L , Mas R , et al. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia. Int J Clin Pharmacol Res . 2002;22:55–66.12503776
  • Torres O , Agramonte AJ , Illnait J , Mas Ferreiro R , Fernandez L , Fernandez JC . Treatment of hypercholesterolemia in NIDDM with policosanol. Diabetes Care . 1995;18:393–397. doi:10.2337/diacare.18.3.393 7555484
  • Castano G , Mas R , Arruzazabala ML , et al. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. Int J Clin Pharmacol Res . 1999;19:105–116.10939028
  • Fernandez JC , Mas R , Castano G , et al. Comparison of the efficacy, safety and tolerability of policosanol versus fluvastatin in elderly hypercholesterolaemic women. Clin Drug Invest . 2001;21:103–113. doi:10.2165/00044011-200121020-00003
  • Castano G , Mas R , Fernandez L , et al. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia. Drugs Aging . 2003;20:153–163. doi:10.2165/00002512-200320020-00006 12534315
  • Greyling A , De Witt C , Oosthuizen W , Jerling JC . Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr . 2006;95:968–975. doi:10.1079/bjn20061715 16611388
  • Berthold HK , Unverdorben S , Degenhardt R , Bulitta M , Gouni-Berthold I . Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA . 2006;295:2262–2269. doi:10.1001/jama.295.19.2262 16705107
  • Francini-Pesenti F , Beltramolli D , Dall’Acqua S , Brocadello F . Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia. Phytother Res . 2008;22:318–322. doi:10.1002/ptr.2315 18167048
  • Francini-Pesenti F , Brocadello F , Beltramolli D , Nardi M , Caregaro L . Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study. Complement Ther Med . 2008;16:61–65. doi:10.1016/j.ctim.2007.08.003 18514906
  • Lin Y , Rudrum M , van der Wielen RP , et al. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations. Metabolism . 2004;53:1309–1314. doi:10.1016/j.metabol.2004.05.006 15375787
  • Dulin MF , Hatcher LF , Sasser HC , Barringer TA . Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Am J Clin Nutr . 2006;84:1543–1548. doi:10.1093/ajcn/84.6.1543 17158441
  • European Food Safety Authority. Scientific opinion on the substantiation of health claims related to policosanols from sugar cane wax and maintenance of normal blood LDL-cholesterol concentrations (ID 1747, 1748, 1864, 1951, 1954, 4693) and maintenance of normal blood HDL-cholesterol concentrations (ID 1747, 1748, 1864, 1951, 1954, 4693) pursuant to Article 13 (1)of Regulation (EC) No 1924/2006. Efsa J . 2011;9(6):2255.
  • Racette SB , Lin X , Ma L , Ostlund RE Jr. Natural dietary phytosterols. J AOAC Int . 2015;98:679–684. doi:10.5740/jaoacint.SGERacette 26086252
  • Cho KH , Yadav D , Kim SJ , Kim JR . Blood pressure lowering effect of cuban policosanol is accompanied by improvement of hepatic inflammation, lipoprotein profile, and HDL quality in spontaneously hypertensive rats. Molecules . 2018;3:23.
  • Park HJ , Yadav D , Jeong DJ , et al. Short-term consumption of Cuban policosanol lowers aortic and peripheral blood pressure and ameliorates serum lipid parameters in healthy Korean participants: randomized, double-blinded, and placebo-controlled study. Int J Environ Res Public Health . 2019;5:16.
  • Vanhanen HT , Miettinen TA . Effects of unsaturated and saturated dietary plant sterols on their serum contents. Clin Chim Acta . 1992;205:97–107. doi:10.1016/s0009-8981(05)80004-x 1521345
  • Ostlund RE , McGill JB , Zeng CM , et al. Gastrointestinal absorption and plasma kinetics of soy delta(5)-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab . 2002;282:E911–E916. doi:10.1152/ajpendo.00328.2001 11882512
  • Ostlund RE . Phytosterols, cholesterol absorption and healthy diets. Lipids . 2007;42:41–45. doi:10.1007/s11745-006-3001-9 17393209
  • Ikeda I , Tanaka K , Sugano M , Vahouny GV , Gallo LL . Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res . 1988;29:1573–1582.2468730
  • Pollak OJ . Reduction of blood cholesterol in man. Circulation . 1953;7:702–706. doi:10.1161/01.cir.7.5.702 13042924
  • Rozner S , Garti N . The activity and absorption relationship of cholesterol and phytosterols. Colloids Surf A . 2006;282-283:435–456. doi:10.1016/j.colsurfa.2005.12.032
  • Shaghaghi MA , Abumweis SS , Jones PJH . Cholesterol-lowering efficacy of plant sterols/stanols provided in capsule and tablet formats: results of a systematic review and meta-analysis. J Acad Nutr Diet . 2013;113:1494–1503. doi:10.1016/j.jand.2013.07.006 24144075
  • Rideout TC , Marinangeli CP , Harding SV . Triglyceride-lowering response to plant sterol and stanol consumption. J AOAC Int . 2015;98:707–715. doi:10.5740/jaoacint.SGERideout 25941890
  • Rocha VZ , Ras RT , Gagliardi AC , Mangili LC , Trautwein EA , Santos RD . Effects of phytosterols on markers of inflammation: a systematic review and meta-analysis. Atherosclerosis . 2016;248:76–83. doi:10.1016/j.atherosclerosis.2016.01.035 26987068
  • Ras RT , Fuchs D , Koppenol WP , et al. The effect of a low-fat spread with added plant sterols on vascular function markers: results of the investigating vascular function effects of plant sterols (INVEST) study. Am J Clin Nutr . 2015;101:733–741. doi:10.3945/ajcn.114.102053 25809853
  • Sudhop T , Gottwald BM , von Bergmann K . Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism . 2002;51:1519–1521. doi:10.1053/meta.2002.36298 12489060
  • Assmann G , Cullen P , Erbey J , Ramey DR , Kannenberg F , Schulte H . Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr Metab Cardiovasc Dis . 2006;16:13–21. doi:10.1016/j.numecd.2005.04.001 16399487
  • Silbernagel G , Fauler G , Hoffmann MM , et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J Lipid Res . 2010;51:2384–2393. doi:10.1194/jlr.P002899 20228406
  • Windler E , Zyriax BC , Kuipers F , Linseisen J , Boeing H . Association of plasma phytosterol concentrations with incident coronary heart disease Data from the CORA study, a case-control study of coronary artery disease in women. Atherosclerosis . 2009;203:284–290. doi:10.1016/j.atherosclerosis.2008.06.014 18656878
  • Genser B , Silbernagel G , De Backer G , et al. Plant sterols and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J . 2012;33:444–451. doi:10.1093/eurheartj/ehr441 22334625
  • Ras RT , van der Schouw YT , Trautwein EA , Sioen I , Dalmeijer G , Zock PL . Intake of phytosterols from natural sources and risk of cardiovascular disease in the European Prospective Investigation into Cancer and Nutrition-the Netherlands (EPIC-NL) population. Eur J Prev Cardiol . 2015;22:1067–1075. doi:10.1177/2047487314554864 25305273
  • Baumgartner S , Ras RT , Trautwein EA , Mensink RP , Plat J . Plasma fat-soluble vitamin and carotenoid concentrations after plant sterol and plant stanol consumption: a meta-analysis of randomized controlled trials. Eur J Nutr . 2017;56:909–923. doi:10.1007/s00394-016-1289-7 27591863
  • Tao C , Shkumatov AA , Alexander ST , Ason BL , Zhou M . Stigmasterol accumulation causes cardiac injury and promotes mortality. Commun Biol . 2019;2:20. doi:10.1038/s42003-018-0245-x 30675518